Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Editorial

Hepatocellular carcinoma surveillance after sustained virological response in chronic hepatitis C: Editorial on “Non-invasive prediction of post-sustained virological response hepatocellular carcinoma in hepatitis C virus: A systematic review and meta-analysis”

Ho Soo Chun, Minjong Lee

Clin Mol Hepatol. 2025;31(1):261-263. Published online September 20, 2024

DOI: https://doi.org/10.3350/cmh.2024.0795

View: 1254 Download: 37

The effect of alanine aminotransferase dynamics on predicting sustained virological response in chronic hepatitis C virus infection

Tae Yeob Kim

Clin Mol Hepatol. 2012;18(1):29-31. Published online March 22, 2012

DOI: https://doi.org/10.3350/kjhep.2012.18.1.29

View: 7986 Download: 37 Crossref: 4

Original Article

Durability of a sustained virological response in chronic hepatitis C patients treated with pegylated interferon alfa and ribavirin

Sang Bun Choi, Youn Jae Lee, Jae Ik Lee, Young Jin Song, Byoung Jin Choi, Jong Han Kim, Eun Uk Jung, Sung Jae Park, Sang Heon Lee, Ji Hyun Kim, Jung Sik Choi, Sam Ryong Jee, Sang Yong Seol

Clin Mol Hepatol. 2011;17(3):183-188. Published online September 30, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.3.183

View: 7982 Download: 39 Crossref: 3

Editorial

Durability of antiviral therapy for chronic hepatitis C after achieving sustained virological response

Jeong Heo

Clin Mol Hepatol. 2011;17(3):180-182. Published online September 30, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.3.180

View: 6978 Download: 34

3

Comparison of therapeutic results between combination therapy of peginterferon alpha-2a plus ribavirin and interferon alpha-2b plus ribavirin according to treatment duration in patients with chronic hepatitis C

Heon Ju Lee , Jong Ryul Eun , Jae Won Choi , Kyung Ok Kim , Hee Jung Moon

Clin Mol Hepatol. 2008;14(1):46-57. Published online March 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.1.46

View: 5106 Download: 20 Crossref: 15

Original Article

Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: A nationwide cohort study

Shou-Wu Lee, Sheng-Shun Yang, Pei-Chien Tsai, Chung-Feng Huang, Chi-Yi Chen, Chao-Hung Hung, Chien-Hung Chen, Chi-Ming Tai, Pin-Nan Cheng, Hsing-Tao Kuo, Kuo-Chih Tseng, Lein-Ray Mo, Ching-Chu Lo, Yi-Hsiang Huang, Han-Chieh Lin, Pei-Lun Lee, Ming-Jong Bair, Te-Sheng Chang, Chun-Yen Lin, Szu-Jen Wang, Tsai-Yuan Hsieh, Tzeng-Hue Yang, Cheng-Yuan Peng, Chi-Chieh Yang, Lee-Won Chong, Chien-Wei Huang, Chih-Wen Lin, Cheng-Hsin Chu, Ming-Chang Tsai, Jia-Horng Kao, Chun-Jen Liu, Wan-Long Chuang, Teng-Yu Lee, Ming- Lung Yu, on behalf of TACR investigators

Received November 10, 2024 Accepted January 16, 2025

DOI: https://doi.org/10.3350/cmh.2024.1015 [Accepted]

View: 1511 Download: 112

Correspondence

Emerging evidence supports direct-acting antiviral therapy for HCC patients beyond the early stage

Teng-Yu Lee, Pei-Chien Tsai, Shou-Wu Lee, Ming- Lung Yu

Received February 28, 2025 Accepted March 1, 2025

DOI: https://doi.org/10.3350/cmh.2025.0235 [Accepted]

View: 482 Download: 18

1 |

Viewed By 10564	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7443	MAFLD: How is it different from NAFLD?
Viewed By 5386	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4819	Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Viewed By 4809	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma

Cited By 338	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 305	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 210	MAFLD: How is it different from NAFLD?
Cited By 104	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Cited By 104	Non-alcoholic fatty liver disease: Definition and subtypes

Search